Acutus Medical, Inc. AFIB
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 95.84% | 57.64% | 95.02% | 90.07% | -323.49% |
| Total Depreciation and Amortization | 1,186.96% | -21.41% | -18.21% | 2.72% | -101.41% |
| Total Amortization of Deferred Charges | 91.46% | 48.67% | 89.81% | -16.35% | 125.69% |
| Total Other Non-Cash Items | -122.19% | 115.34% | -204.63% | -1,511.13% | 174.31% |
| Change in Net Operating Assets | 122.98% | -102.39% | -266.91% | -386.73% | -358.03% |
| Cash from Operations | 77.47% | 73.60% | 54.62% | -7.64% | -38.79% |
| Capital Expenditure | -96.28% | 98.78% | 94.95% | -320.00% | 164.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -57.06% | -100.00% |
| Other Investing Activities | -100.00% | -99.87% | -90.36% | 217.90% | 263.43% |
| Cash from Investing | -51.22% | -82.44% | -70.48% | -39.47% | -8.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | 6.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 57.55% | 100.00% | 104.35% | 80.65% | -53,100.00% |
| Cash from Financing | 54.55% | 100.00% | -12,395.24% | 80.28% | -3,200.00% |
| Foreign Exchange rate Adjustments | -90.14% | -121.15% | -100.46% | -- | 8,575.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.97% | -169.19% | -2,951.11% | -426.24% | -510.56% |